Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nallakannu, Lakshmanan"'
Autor:
Dharanesh Gangaiah, Valerie Ryan, Daphne Van Hoesel, Shrinivasrao P. Mane, Enid T. Mckinley, Nallakannu Lakshmanan, Nandakumar D. Reddy, Edward Dolk, Arvind Kumar
Publikováno v:
MicrobiologyOpen, Vol 11, Iss 2, Pp n/a-n/a (2022)
Abstract Necrotic enteritis (NE), caused by Clostridium perfringens, is an intestinal disease with devastating economic losses to the poultry industry. NE is a complex disease and predisposing factors that compromise gut integrity are required to fac
Externí odkaz:
https://doaj.org/article/42001f8db09b4fa584b7dadb082b34fb
Autor:
Dharanesh Gangaiah, Shrinivasrao P. Mane, Nilesh R. Tawari, Nallakannu Lakshmanan, Valerie Ryan, Alyssa Volland, Dwi Susanti, Milind Patel, Abraham Abouzeid, Emily B. Helmes, Arvind Kumar
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
The last two decades have witnessed a tremendous growth in probiotics and in the numbers of publications on their potential health benefits. Owing to their distinguishing beneficial effects and long history of safe use, species belonging to the Lacto
Externí odkaz:
https://doaj.org/article/b86234e7f6984eb7abf8b6574142e02d
Autor:
Huchappa Jayappa, Ronald D. Schultz, Bliss Thiel, Tamara Davis, Nallakannu Lakshmanan, Jamie Henningson, Muralidhar S. Deshpande, Patricia Sharp, Terri Lee Wasmoen, Laurie J. Larson
Publikováno v:
Clinical and Vaccine Immunology
Since first emerging in the North American canine population in 2004, canine influenza virus (CIV) subtype H3N8 has shown horizontal transmission among dogs, with a high level of adaptation to this species. The severity of disease is variable, and co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e87e4061f9b58b3a00d266d26fa0ccc6
Autor:
Laurie J. Larson, Muralidhar S Deshp, Patricia Sharp, Huchappa Jayappa, Tamara Davis, Nallakannu Lakshmanan, Jamie Henningson, Ronald D. Schultz, Terri Lee Wasmoen, Marie E Pinkerton, Bliss Thiel
Publikováno v:
Journal of Veterinary Science & Medical Diagnosis.
Efficacy of Canine Influenza Virus (H3N8) Vaccine to Reduce Pulmonary Lesions after Co-challenge with Canine Influenza Virus and Streptococcus equi subsp. zooepidemicus To examine the effectiveness of canine influenza vaccination to reduce pulmonary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebf556a302596eb361aeaaec43c3bb44
https://doi.org/10.4172/2325-9590.1000111
https://doi.org/10.4172/2325-9590.1000111
Autor:
Muralidhar S, Deshpande, Faris F, Jirjis, Anna L, Tubbs, Huchappa, Jayappa, Diane, Sweeney, Stephen J, Spencer, Nallakannu, Lakshmanan, Terri L, Wasmoen
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 10(3)
Canine influenza virus (CIV) subtype H3N8 is an emerging pathogen with sustained horizontal transmission in the dog population in the United States. This study evaluated the efficacy of an inactivated CIV vaccine in 6- to 8-week-old beagle pups chall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::994a023384a23e9e407b8b8002528d89
https://pubmed.ncbi.nlm.nih.gov/20037964
https://pubmed.ncbi.nlm.nih.gov/20037964
Autor:
Terri Lee Wasmoen, Huchappa Jayappa, Faris F Jirjis, Anna L. Tubbs, Nallakannu Lakshmanan, Muralidhar S. Deshpande
Publikováno v:
Veterinary microbiology. 144(3-4)
Canine influenza virus (CIV) is an emerging pathogen that causes acute respiratory disease in dogs. As with any communicable disease, dog-to-dog transmission of CIV occurs when infected dogs come in contact with other susceptible dogs. We demonstrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d20210764433b747dafe7ee7bc4e7aa
https://pubmed.ncbi.nlm.nih.gov/20347235
https://pubmed.ncbi.nlm.nih.gov/20347235
Autor:
Thomas C, Gore, Nallakannu, Lakshmanan, James R, Williams, Faris F, Jirjis, S Theodore, Chester, Karen L, Duncan, Michael J, Coyne, Melissa A, Lum, Frank J, Sterner
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 7(3)
Forty-two seronegative cats received an initial vaccination at 8 weeks of age and a booster vaccination at 12 weeks. All cats were kept in strict isolation for 3 years after the second vaccination and then were challenged with feline calicivirus (FCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9bd18ed64754f0dcd5c15e2708703f6
https://pubmed.ncbi.nlm.nih.gov/17039444
https://pubmed.ncbi.nlm.nih.gov/17039444
Autor:
Nallakannu, Lakshmanan, Thomas C, Gore, Karen L, Duncan, Michael J, Coyne, Melissa A, Lum, Frank J, Sterner
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 7(3)
Thirty-two seronegative pups were vaccinated at 8 weeks of age with modified-live canine distemper virus (CDV), canine adenovirus type-2 (CAV-2), and canine parvovirus (CPV) vaccine and at 12 weeks with a modified-live CDV, CAV-2, CPV, and killed rab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7975bbdd704dfcea69c274c365878b6
https://pubmed.ncbi.nlm.nih.gov/17039445
https://pubmed.ncbi.nlm.nih.gov/17039445
Autor:
Thomas C, Gore, Nallakannu, Lakshmanan, Karen L, Duncan, Michael J, Coyne, Melissa A, Lum, Frank J, Sterner
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 6(1)
A challenge-of-immunity study was conducted to demonstrate immunity in dogs 3 years after their second vaccination with a new multivalent, modified-live vaccine containing canine adenovirus type 2 (CAV-2), canine parvovirus (CPV), and canine distempe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::50d9a965fb60ff941578c5759cc68a23
https://pubmed.ncbi.nlm.nih.gov/15906266
https://pubmed.ncbi.nlm.nih.gov/15906266